This has been a rough year for Zosano. Novo Nordisk ($NVO) dumped their diabetes collaboration in July. The biotech pulled off an IPO in January, but its stock price quickly plunged.
Fierce Biotech · ByJohn Carroll · 9/29/2015
The Food and Drug Administration said it was concerned a proposed, long-acting insulin product being developed by Novo Nordisk A/S (NVO, NOVO-B.KO ... of the FDA review Tuesday (Updates with impact on stock price and adds additional information …
Market Watch · 11/6/2012
Its ADSs are listed on the New York Stock Exchange under the symbol "NVO." Abbott Laboratories is a global, diversified health care company devoted to the discovery, development, manufacture and marketing of pharmaceutical, diagnostic, nutritional and ... · 12/3/1997
It has also taken on process-development work for Western drugmakers, including GlaxoSmithKline ($GSK) and Novo Nordisk ($NVO), through its A-Bio Pharma ... already committed to buy $280 million in stock, including Orbimed and Prime Capital, which …
FiercePharma · ByTracy Staton · 6/23/2014
Following the above-mentioned changes, Novo Nordisk's Executive Management is now composed as follows ... Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit
Virtual-Strategy Magazine · 11/24/2014
Qsymia sales have underwhelmed investors' expectations in 2014, and the stock traded down about 65 percent ... In other news, the FDA recently approved Novo Nordisk A/S (ADR) (NYSE: NVO)'s Saxenda as a treatment for obesity. Saxenda is a larger …
Benzinga · 1/14/2015
162 companies with headquarter in Europe are listed on an American Stock Exchange. 102 of them pay dividends and ... 1.64 percent and the beta ratio has a value of 0.89. Novo Nordisk (NVO) has a market capitalization of $120.37 billion.
Trefis · 1/31/2013
The stock market snapped its two-day skid on Wednesday ... SABR, TRS, AVT, KERX, LDOS, LPLA, NVO, BBW, GTXI, ICD, NYT, BXLT, LANC, SXI, RGS
Briefing Live Market Analysis · 10/28/2015
Though the world was not taking the real estate czar in the beginning of his campaign seriously, but despite negative media image that he received following the first official Republican presidential candidates debate, his stock rose considerably since then.
NVO News · 8/30/2015
Recently, Sanofi said at its earnings call that its blockbuster diabetes drug Lantus was facing pricing pressure due to low-cost competing drugs from Novo Nordisk A/S (ADR) (NYSE:NVO ... of Afrezza. JPMorgan has a Neutral rating on the stock with ...
Value Walk · ByVikas Shukla · 11/5/2014
VANCOUVER, BC / TheNewswire / September 16, 2015 - Novo Resources Corp. (the "Company") (TSX-V: NVO; OTCQX: NSRPF) is pleased to announce a robust near-surface resource estimate (the "2015 Resource Estimate") for its Beatons Creek Gold …
Stockhouse · 9/16/2015

Novo Nordisk

Novo Nordisk is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in se…
Novo Nordisk is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in seven countries, and affiliates or offices in 75 countries. Novo Nordisk manufactures and markets pharmaceutical products and services. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. The company makes several drugs under various brand names, including Levemir, NovoLog, Novolin R, NovoSeven, NovoEight and Victoza.
Data from: Wikipedia · Freebase